Avandia

250. Big Pharm. The Great Big Drugs Rip-off (Part 3)

GlaxoSmithKline (GSK) In 2012, GSK agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company‚Äôs unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. This blog is based on the press …

250. Big Pharm. The Great Big Drugs Rip-off (Part 3) Read More »

147. Avandia: More Bad News About the Drug Industry

In a previous blog (1) I explained how concerns about the increased incidence of heart attacks associated with treatment for diabetes by the drug Rosiglitazone (marketed by GSK under the brand name Avandia) had resulted in an investigation by the US Senate Finance Committee. The committee staff had access to about 250,000 documents and produced …

147. Avandia: More Bad News About the Drug Industry Read More »

Scroll to Top